Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Boston Scientific Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
A comprehensive shift in the capital structure is observed from March 2018 to March 2023, characterized by a consistent reduction in total liabilities and a corresponding increase in total equity. Total liabilities decreased from 63.39% of total liabilities and equity in the first quarter of 2018 to 44.94% by the first quarter of 2023. Conversely, total equity expanded from 36.61% to 55.06% over the same period, indicating a strengthening of the solvency position and a reduced reliance on external debt financing.
- Current Liabilities Trends
- Current liabilities experienced a significant downward trajectory, falling from 25.98% in March 2018 to 12.41% in March 2023. A primary driver of this decline was the reduction in current debt obligations, which peaked at 10.73% in December 2018 before dropping to near-zero levels (below 1%) for much of 2020 and 2021. Additionally, accrued expenses showed a steady contraction, decreasing from 12.74% to 5.83%, suggesting more efficient management of short-term operational obligations.
- Long-Term Liability Dynamics
- Long-term liabilities remained more stable than current liabilities but still trended slightly downward from 37.41% to 32.53%. Long-term debt exhibited some volatility, peaking at 35.84% in September 2019 before settling at 25.83% by March 2023. Other long-term liabilities also saw a gradual decrease from 11.73% to 6.07%, further contributing to the overall reduction in the company's leverage ratio.
- Equity Composition and Quality
- The most notable change within the equity section is the dramatic reduction of the accumulated deficit. The deficit stood at -43.36% in March 2018 and was systematically reduced to -1.37% by March 2023, reflecting a strong trend of cumulative profitability. This improvement in retained earnings significantly offset the decline in additional paid-in capital, which dropped from 89.50% to 61.89%. Treasury stock remained relatively consistent as a percentage of the total, fluctuating between -5.57% and -8.94%, indicating a steady approach to share repurchases.
- Overall Financial Positioning
- The transition from a liability-heavy balance sheet to one dominated by equity suggests a strategic deleveraging process. The movement of total equity from approximately one-third to over one-half of the total capital structure implies a lower financial risk profile and an enhanced capacity to absorb potential losses or fund future growth internally.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?